These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4981669)

  • 61. [Combined treatment with hydergine and neuroleptics in mental disorders of old age].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1969; 3(3):327-32. PubMed ID: 4980081
    [No Abstract]   [Full Text] [Related]  

  • 62. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 63. The physician depression scale (PDS): a factor analytic study.
    Rickels K; Downing RW; Spaeth H
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Nov; 6(6):280-6. PubMed ID: 4605313
    [No Abstract]   [Full Text] [Related]  

  • 64. [Double-blind controlled trial on treatment of psychosomatic syndromes by a new tranquilizer combination].
    Mereto GC
    Minerva Med; 1974 Mar; 65(17):923-35. PubMed ID: 4596804
    [No Abstract]   [Full Text] [Related]  

  • 65. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E; D'Alise R; Mea A; Vitagliano A
    Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
    [No Abstract]   [Full Text] [Related]  

  • 66. [Clinico-rheoencephalographic characteristics and criteria for different initial forms of atherosclerotic brain lesions].
    Laptev AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1152-8. PubMed ID: 7315049
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study.
    Enger E; Boyesen S
    Acta Med Scand Suppl; 1965; 438():1-61. PubMed ID: 5323519
    [No Abstract]   [Full Text] [Related]  

  • 68. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
    Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
    [No Abstract]   [Full Text] [Related]  

  • 69. Trazodone in the treatment of psychoneuroses: a double-blind study.
    Antonelli F; De Gregorio M; Dionisio A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):799-804. PubMed ID: 4201978
    [No Abstract]   [Full Text] [Related]  

  • 70. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 71. [A new stimulating agent of cerebrovascular circulation].
    Moreau P
    Nouv Presse Med; 1975 Oct; 4(33):2401-2. PubMed ID: 1105410
    [No Abstract]   [Full Text] [Related]  

  • 72. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)].
    Pires de Oliveira RS
    Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581
    [No Abstract]   [Full Text] [Related]  

  • 73. [Therapy of headaches, including migraine].
    von Albert HH; Marguth F
    Bibl Psychiatr Neurol; 1969; 139():152-8. PubMed ID: 5002864
    [No Abstract]   [Full Text] [Related]  

  • 74. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 75. [Tranxillium 20 (dipotassium chlorazepate) as a 24-hr tranquilizer].
    Skupin G; Franzke HG
    Med Welt; 1975 May; 26(19):956-9. PubMed ID: 237172
    [No Abstract]   [Full Text] [Related]  

  • 76. [Treatment of chronic cerebrovascular insufficiency and chronic obliterating arteriopathy of the lower extremities with buflomedil hydrochloride].
    Salerno L; Sallì L; Pepe S; Curiale B; Allegra G; Scalici G; Salvato F
    Minerva Med; 1985 Sep; 76(36):1611-8. PubMed ID: 4047447
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The effect of pentetrazole on serum cholesterol level and on behavior of patients with cerebral arteriosclerosis].
    Merkus JW
    Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1634-8. PubMed ID: 4878453
    [No Abstract]   [Full Text] [Related]  

  • 78. [Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group].
    Appel P; Berger I; Harrer G
    Arzneimittelforschung; 1971 Jul; 21(7):1083-6. PubMed ID: 4935400
    [No Abstract]   [Full Text] [Related]  

  • 79. [Captagon--a new psychotonic agent].
    Bryś J; Tomaszewski K; Wasik A; Bukowczyk A
    Psychiatr Pol; 1969; 3(3):341-6. PubMed ID: 5805112
    [No Abstract]   [Full Text] [Related]  

  • 80. [Objective methods in testing of a new tranquilizer in geriatrics].
    Danielczyk W
    Med Welt; 1968 Mar; 9():580-3. PubMed ID: 5719394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.